|
News Press Releases and Articles Calendar of Events How to Help Gates Foundation Grant to GAELF The Global Alliance Global Alliance History Goals Global Alliance Structure Executive Group Partnerships GAELF Logo LF Webring About LF What is LF? How is LF Contracted? How is LF Diagnosed? Prevent/Eliminate LF Manage LF LF and Children Additional Treatment Benefits LF Slideshow In Depth Disease Info Where is LF? Countries and Map List Moving Forward Starting Out Success Stories Progress and Plans Elimination Strategy Operational Research Progress to Date Economics of LF Return on Investment The Way Ahead Highlighted Programmes Burkina Faso Sri Lanka For the Media Press Release Archive Press Kits Photos Articles Video Clips Media Contacts FAQs Publications LF News Annual Reports General Publications Training Material Videos Journal Articles & Other Pubs EG Updates Gates Foundation |
![]() |
| Asymptomatic
Presentations
Of all the individuals with lymphatic filariasis less than half appear clinically asymptomatic, though they have microfilariae circulating in their blood and yet all have hidden damage to their lymphatic (as evidenced by lymphoscintigraphy) and/or renal systems (microscopic heamaturia and/or proteinuria). It is clear that this state of asymptomatic microfilaraemia is associated with a highly down-regulated immune system, but it is as yet unclear how, when or even whether these individuals will progress to develop one of the more overt clinical manifestations of filarial disease. A second asymptomatic 'presentation' exists in individuals previously termed 'endemic normals'; their infections are defined not by microfilaraemia but by the presence of parasite antigen in the blood (which will disappear after appropriate treatment). It has only recently been possible to recognize this group of patients, and both their clinical features and sequelae of infection remain to be defined. |
|
|
© Global Alliance to Eliminate Lymphatic Filariasis |